Correlation Between Hudson Pacific and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Hudson Pacific and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hudson Pacific and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hudson Pacific Properties and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Hudson Pacific and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hudson Pacific with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hudson Pacific and Regeneron Pharmaceuticals.
Diversification Opportunities for Hudson Pacific and Regeneron Pharmaceuticals
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hudson and Regeneron is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Hudson Pacific Properties and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Hudson Pacific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hudson Pacific Properties are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Hudson Pacific i.e., Hudson Pacific and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Hudson Pacific and Regeneron Pharmaceuticals
Considering the 90-day investment horizon Hudson Pacific Properties is expected to under-perform the Regeneron Pharmaceuticals. In addition to that, Hudson Pacific is 2.57 times more volatile than Regeneron Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 76,136 in Regeneron Pharmaceuticals on December 1, 2024 and sell it today you would lose (6,262) from holding Regeneron Pharmaceuticals or give up 8.22% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Hudson Pacific Properties vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Hudson Pacific Properties |
Regeneron Pharmaceuticals |
Hudson Pacific and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hudson Pacific and Regeneron Pharmaceuticals
The main advantage of trading using opposite Hudson Pacific and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hudson Pacific position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Hudson Pacific vs. Kilroy Realty Corp | Hudson Pacific vs. Highwoods Properties | Hudson Pacific vs. Cousins Properties Incorporated | Hudson Pacific vs. Piedmont Office Realty |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Stocks Directory Find actively traded stocks across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |